mRNA |
selumetinib:vorinostat (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.0009 |
mRNA |
selumetinib:navitoclax (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.001 |
mRNA |
erlotinib:PLX-4032 (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.001 |
mRNA |
dabrafenib |
GDSC1000 |
pan-cancer |
AAC |
0.095 |
0.001 |
mRNA |
selumetinib:tretinoin (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.002 |
mRNA |
crizotinib:PLX-4032 (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.002 |
mRNA |
PLX4720 |
CCLE |
pan-cancer |
AAC |
0.13 |
0.002 |
mRNA |
BRD-K45681478 |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.003 |
mRNA |
FH535 |
GDSC1000 |
pan-cancer |
AAC |
0.097 |
0.004 |
mRNA |
Topotecan |
CCLE |
pan-cancer |
AAC |
-0.12 |
0.004 |